Caris Life Sciences, Inc. Common Stock (CAI) Stock Price

CAIStock

$28.01−33.51%52W

Market Cap$7.92B

P/E—

PEG Ratio—

Div yield—

Beta0.40

CAI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)12.89%

Price vs S&P 500 (4W)64.56%

VGM Score58.56

P/CF (Annual)75.38x

Book Value / Share (Quarterly)$2.09

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$0.44

Price vs S&P 500 (YTD)-15.11%

Gross Margin (TTM)69.66%

Net Profit Margin (TTM)10.62%

EPS (TTM)$0.37

10-Day Avg Trading Volume4.81M

EPS Excl Extra (TTM)$0.37

EPS (Annual)$-0.41

ROI (Annual)-7.12%

Gross Margin (Annual)66.63%

Cash / Share (Quarterly)$2.81

P/E Basic Excl Extra (TTM)59.62x

Revenue Growth QoQ (YoY)45.38%

ROA (Last FY)-6.05%

Revenue Growth TTM (YoY)38.49%

EBITD / Share (TTM)$0.51

Operating Margin (TTM)12.74%

Cash Flow / Share (Annual)$0.24

P/B Ratio10.59x

P/B Ratio (Quarterly)8.51x

Net Income / Employee (Annual)$-36,900

EV / Revenue (TTM)6.03x

Net Interest Coverage (TTM)0.27x

ROA (TTM)9.34%

EV / EBITDA (TTM)40.66x

EPS Incl Extra (Annual)$-0.41

Current Ratio (Annual)7.85x

Quick Ratio (Quarterly)4.78x

3-Month Avg Trading Volume3.50M

52-Week Price Return-33.51%

EV / Free Cash Flow (Annual)89.25x

P/E Incl Extra (TTM)59.62x

Revenue / Employee (TTM)$536,100

P/S Ratio (Annual)7.72x

Asset Turnover (Annual)0.72x

52-Week High$42.50

EPS Excl Extra (Annual)$-0.41

26-Week Price Return24.13%

Quick Ratio (Annual)7.19x

13-Week Price Return63.93%

Total Debt / Equity (Annual)0.66x

Current Ratio (Quarterly)5.53x

Enterprise Value$5.97B

Asset Turnover (TTM)0.88x

Revenue / Employee (Annual)$439,900

Pretax Margin (Annual)-8.38%

Cash / Share (Annual)$2.83

3-Month Return Std Dev75.45%

Net Income / Employee (TTM)$57,000

ROE (Last FY)-11.79%

Net Interest Coverage (Annual)6.01x

EPS Basic Excl Extra (Annual)$-0.41

P/FCF (TTM)50.57x

Receivables Turnover (TTM)11.80x

EV / Free Cash Flow (TTM)48.16x

Total Debt / Equity (Quarterly)0.66x

EPS Incl Extra (TTM)$0.37

ROI (TTM)11.15%

P/S Ratio (TTM)6.33x

Revenue / Share (Annual)$4.86

Forward P/E66.62x

Price vs S&P 500 (52W)-51.82%

P/E Ratio (TTM)59.62x

Year-to-Date Return-3.15%

5-Day Price Return24.61%

EPS Normalized (Annual)$-0.41

Net Profit Margin (Annual)-8.38%

Month-to-Date Return66.75%

EBITD / Share (Annual)$0.15

Operating Margin (Annual)3.11%

LT Debt / Equity (Annual)0.66x

P/CF (TTM)37.19x

P/E Excl Extra (TTM)59.62x

LT Debt / Equity (Quarterly)0.66x

EPS Basic Excl Extra (TTM)$0.37

P/B Ratio (Annual)13.19x

Inventory Turnover (TTM)3.65x

Pretax Margin (TTM)10.61%

Book Value / Share (Annual)$2.04

Price vs S&P 500 (13W)61.13%

Beta0.40x

P/FCF (Annual)93.70x

Revenue / Share (TTM)$3.50

ROE (TTM)18.77%

52-Week Low$14.19

vGradeF

gGradeA

mGradeB

vgmGradeC

CAI Earnings Surprise History

Q2 25-1.11est. -0.22

Q3 250.08est. -0.14

Q4 250.28est. 0.10

Q1 260.00est. -0.02

Q2 260.00est. 0.01

CAI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.24

4.31

4.19

4.13

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Caris Life Sciences, Inc. Common Stock

Caris Life Sciences develops AI-powered molecular diagnostic solutions for oncology, enabling personalized cancer treatment decisions. The company leverages comprehensive molecular profiling and machine learning algorithms to provide physicians with precision medicine insights. Its technology platform aims to improve patient outcomes while supporting clinical and pharmaceutical decision-making.